{"nct_id":"NCT01478048","title":"Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2018-04","start_date":"2011-11-30","start_date_type":"ACTUAL","primary_completion_date":"2014-05-30","primary_completion_date_type":"ACTUAL","completion_date":"2017-04-21","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}